Atorvastatinfigure1 (Atorvastatinfigure1)
Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7575
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)
This text provides information about the cumulative incidence (%) comparing results between Atorvastatin and Placebo over a period of 2.0 to 3.5 years. The data shows a Hazard Ratio (HR) of 0.64 with confidence intervals (0.50-0.83) and a p-value of 0.0005.*
Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)
This text is providing information on cumulative hazard (%) over time for Placebo and Atorvastatin. It includes hazard ratio (HR) with 95% confidence interval and p-value for the comparison. The data is specifically related to the time to the first primary endpoint through four years of follow-up.*
Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)
This data pertains to a study comparing the effects of Atorvastatin 10 mg and Atorvastatin 80 mg on the occurrence of a major cardiovascular endpoint over a certain period of time. The hazard ratio (HR) between the two doses at an interval of 0.78 with a confidence interval of (0.69 - 0.89) and a p-value of 0.0002 suggests a statistically significant difference.*
Label Image (Lbl500907575)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
